INSIDER · CIK 1603347
Huizenga Theodore Alan
SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$20KSold on the market
1Companies
Sep 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202618:57 | Sep 15, 2026 | RAREUltragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | S · Sell10b5-1 | $13.57 | −1,283 | 67,863 | -2% | −$17K | ||
| Sep 8, 202612:29 | Sep 3, 2026 | RAREUltragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | S · SellLate 5d | $13.99 | −161 | 69,146 | -0% | −$2K |